X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6765) 6765
Publication (924) 924
Book Chapter (34) 34
Book Review (23) 23
Dissertation (22) 22
Conference Proceeding (17) 17
Book / eBook (4) 4
Magazine Article (3) 3
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4343) 4343
index medicus (4140) 4140
female (3967) 3967
breast cancer (3835) 3835
oncology (3058) 3058
triple negative breast neoplasms - pathology (2183) 2183
triple-negative breast cancer (2006) 2006
middle aged (1679) 1679
cancer (1651) 1651
cell line, tumor (1517) 1517
prognosis (1488) 1488
adult (1387) 1387
triple negative breast neoplasms - genetics (1384) 1384
metastasis (1377) 1377
triple negative breast neoplasms - metabolism (1343) 1343
triple negative breast neoplasms - drug therapy (1299) 1299
chemotherapy (1286) 1286
expression (1280) 1280
aged (1202) 1202
triple negative breast cancer (1168) 1168
tumors (1119) 1119
animals (1077) 1077
breast neoplasms - pathology (969) 969
survival (928) 928
gene expression (827) 827
analysis (824) 824
apoptosis (809) 809
mice (807) 807
research (770) 770
breast neoplasms - metabolism (746) 746
immunohistochemistry (723) 723
cell biology (705) 705
care and treatment (670) 670
health aspects (637) 637
article (634) 634
gene expression regulation, neoplastic (633) 633
cancer therapies (621) 621
therapy (596) 596
receptor, erbb-2 - metabolism (592) 592
medical prognosis (583) 583
carcinoma (581) 581
genetic aspects (570) 570
cells (569) 569
medicine & public health (561) 561
triple negative (555) 555
breast (548) 548
receptors, estrogen - metabolism (542) 542
proteins (524) 524
subtypes (517) 517
neoplasm staging (510) 510
disease-free survival (503) 503
aged, 80 and over (484) 484
breast neoplasms - genetics (476) 476
pathology (475) 475
triple negative breast neoplasms - mortality (465) 465
receptors, progesterone - metabolism (456) 456
treatment outcome (454) 454
cell proliferation - drug effects (452) 452
breast neoplasms - drug therapy (447) 447
growth (447) 447
estrogen (445) 445
research article (434) 434
antineoplastic agents - pharmacology (431) 431
development and progression (430) 430
retrospective studies (425) 425
biochemistry & molecular biology (406) 406
cell proliferation (405) 405
mutation (404) 404
epidermal growth factor (399) 399
phenotype (398) 398
xenograft model antitumor assays (397) 397
neoadjuvant chemotherapy (394) 394
signal transduction (386) 386
antineoplastic combined chemotherapy protocols - therapeutic use (378) 378
biomarkers, tumor - metabolism (372) 372
medicine (368) 368
metastases (367) 367
antineoplastic agents - therapeutic use (361) 361
triple negative breast neoplasms - therapy (360) 360
apoptosis - drug effects (351) 351
identification (346) 346
kinases (343) 343
kaplan-meier estimate (342) 342
activation (338) 338
biomarkers (337) 337
women (336) 336
risk factors (335) 335
skin and connective tissue diseases (335) 335
patients (334) 334
surgery (330) 330
research paper (329) 329
proliferation (328) 328
breast neoplasms - mortality (326) 326
studies (325) 325
medicine, research & experimental (320) 320
inhibition (319) 319
epithelial-mesenchymal transition (313) 313
estrogen-receptor (312) 312
cancer research (311) 311
mice, nude (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6602) 6602
Chinese (54) 54
French (52) 52
Japanese (31) 31
Spanish (25) 25
Russian (22) 22
German (17) 17
Czech (8) 8
Korean (7) 7
Polish (7) 7
Portuguese (3) 3
Bulgarian (1) 1
Croatian (1) 1
Hungarian (1) 1
Latvian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Case Reports in Oncology, ISSN 1662-6575, 11/2019, Volume 12, Issue 3, pp. 834 - 837
Myelofibrosis (MF) can occur due to a wide variety of causes including malignant lymphoma. We report a case of splenic marginal zone lymphoma complicated by MF... 
pmf | smzl | differential diagnosis | triple-negative | jak2
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 03/2019, Volume 10, Issue 24, p. 2336
Journal Article
04/2012
Background: This study was undertaken to document the pattern of expression of estrogen (ER), progesterone (PR) and human epidermal growth factor receptor-2... 
HER2-targeted therapy | triple negative | India
Web Resource
Annals of Oncology, ISSN 0923-7534, 08/2019, Volume 30, Issue 8, pp. 1289 - 1297
Abstract Background This hypothesis-generating trial evaluated neoadjuvant ipatasertib–paclitaxel for early triple-negative breast cancer (TNBC). Patients and... 
neoadjuvant | triple-negative breast cancer | CARBOPLATIN | PI3K | ONCOLOGY | ipatasertib | PTEN | AKT INHIBITOR
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 03/2020, Volume 235, Issue 3, pp. 2631 - 2642
Triple negative breast cancer (TNBC) is a heterogeneous subclass of breast cancer (BC) distinguished by lack of hormone receptor expression. It is highly... 
triple negative breast cancer | miR‐483‐3p | cancer progression | HDAC8
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2108 - 2121
Journal Article
Oncotarget, ISSN 1949-2553, 08/2018, Volume 9, Issue 63, pp. 32108 - 32118
Triple negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis. In this study, we aimed to conduct a nomogram to predict the survival... 
Prognosis | Predictive accuracy | Nomogram | Triple negative breast cancer
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 02/2020, Volume 235, Issue 2, pp. 1543 - 1555
Triple‐negative breast cancer (TNBC) is associated with a high mortality rate, which is related to the insufficient number of appropriate biomarkers and... 
epithelial–mesenchymal transition | pinin | mesenchymal phenotype | triple‐negative breast cancer | SARNP | E‐cadherin
Journal Article
ISSN 1471-2407, 2018
Background High triglycerides and low levels of high density lipoprotein (HDL)-cholesterol are observed to promote tumor growth. However, whether breast cancer... 
Lipids | Breast cancer | Molecular subtype | Survival | Triple negative breast cancer
Journal Article
Oncotarget, ISSN 1949-2553, 05/2018, Volume 9, Issue 39, pp. 25545 - 25556
Breast cancers can be divided into several types. Because triple-negative breast cancer (TNBC) is the most refractory to current anti-cancer therapies,... 
Bcl-2 | Triple-negative | Breast cancer | Doxorubicin | ABT-199
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.